215 related articles for article (PubMed ID: 28351163)
1. CRP relevance in clinical assessment of chronic spontaneous urticaria Tunisian patients.
Maouia A; Youssef M; Leban N; Ben Chibani J; Helal AN; Kassab A
Cutan Ocul Toxicol; 2017 Dec; 36(4):387-392. PubMed ID: 28351163
[TBL] [Abstract][Full Text] [Related]
2. Influence of desloratadine on oxidative stress markers in patients with chronic idiopathic urticaria.
Cassano N; Raho G; Filieri M; D'Argento V; Amoruso A; Filotico R; Vena GA
Int J Dermatol; 2006 Apr; 45(4):394-6. PubMed ID: 16650165
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria.
Kolkhir P; Altrichter S; Hawro T; Maurer M
Allergy; 2018 Apr; 73(4):940-948. PubMed ID: 29130488
[TBL] [Abstract][Full Text] [Related]
4. Desloratadine Efficacy in Relation to GSTM1 and GSTT1 Polymorphic Genes in Chronic Spontaneous Urticaria.
Maouia A; Leban N; Youssef M; Helal AN; Kassab A
Indian J Dermatol; 2022; 67(3):252-257. PubMed ID: 36386105
[TBL] [Abstract][Full Text] [Related]
5. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
Potter P; Mitha E; Barkai L; Mezei G; Santamaría E; Izquierdo I; Maurer M
Pediatr Allergy Immunol; 2016 Feb; 27(1):55-61. PubMed ID: 26267219
[TBL] [Abstract][Full Text] [Related]
6. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
DuBuske L
Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
Ortonne JP; Grob JJ; Auquier P; Dreyfus I
Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY
Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988
[TBL] [Abstract][Full Text] [Related]
9. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity.
Grattan CE; Dawn G; Gibbs S; Francis DM
Clin Exp Allergy; 2003 Mar; 33(3):337-41. PubMed ID: 12614448
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein (CRP) rs3093059C predicts poor mizolastine response in chronic spontaneous urticaria patients with elevated serum CRP level.
Yan S; Chen W; Peng C; Zhu W; Chen M; Zhang J; Su J; Li F; Liu Z; Zhang W; Li Q; Li J; Chen X
Exp Dermatol; 2019 Mar; 28(3):240-246. PubMed ID: 30632650
[TBL] [Abstract][Full Text] [Related]
11. Platelet oxidative stress and systemic inflammation in chronic spontaneous urticaria.
Rajappa M; Chandrashekar L; Sundar I; Munisamy M; Ananthanarayanan PH; Thappa DM; Toi PCh
Clin Chem Lab Med; 2013 Sep; 51(9):1789-94. PubMed ID: 23612662
[TBL] [Abstract][Full Text] [Related]
12. Influence of component 5a receptor 1 (C5AR1) -1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria.
Yan S; Chen W; Wen S; Zhu W; Guo A; Chen X; Zhang C; Chen M; Zhang J; Su J; Zhao Y; He Y; Liu Z; Zhou H; Zeng W; Li J; Chen X
J Dermatol Sci; 2014 Dec; 76(3):240-5. PubMed ID: 25455139
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria.
Kitsioulis NA; Xepapadaki P; Roussaki-Schulze AV; Papadopoulos N; Zafiriou E
Int Arch Allergy Immunol; 2017; 172(3):161-166. PubMed ID: 28380487
[TBL] [Abstract][Full Text] [Related]
14. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients.
Augustin M; Ehrle S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):292-9. PubMed ID: 19438819
[TBL] [Abstract][Full Text] [Related]
16. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
[TBL] [Abstract][Full Text] [Related]
17. Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria.
Lachapelle JM; Decroix J; Henrijean A; Roquet-Gravy PP; De Swerdt A; Boonen H; Lecuyer M; Suys E; Speelman G; Vastesaeger N
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):288-92. PubMed ID: 16503889
[TBL] [Abstract][Full Text] [Related]
18. [Desloratadine for chronic idiopathic urticaria].
Rottem M; Elbirt D; Sthoeger Z;
Harefuah; 2005 Aug; 144(8):547-53, 599, 598. PubMed ID: 16146151
[TBL] [Abstract][Full Text] [Related]
19. The treatment outcomes and dose de-escalation of desloratadine up-dosing in chronic spontaneous urticaria.
Choonhakarn C; Chaowattanapanit S; Julanon N
Int J Dermatol; 2018 Apr; 57(4):423-427. PubMed ID: 29380864
[TBL] [Abstract][Full Text] [Related]
20. [Association of CACNA1C gene genetic polymorphism with the susceptibility as well as prognosis for chronic spontaneous urticaria].
Yan J; Li Q; Luo Y; Yan S; He Y; Chen X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Sep; 43(9):929-936. PubMed ID: 30333282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
